Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Kenshin Trading Corporation
WARNING LETTER
•Kenshin Trading Corporation•November 30, 2009

Kenshin Trading Corporation – FDA Warning Letter, Nov 30, 2009

Record Details

On December 8, 2009, the FDA issued a Warning Letter to Kenshin Trading Corporation following a November 5, 2009, review of their website, http://www.kenshin.com. The review identified several violations related to the marketing and sale of medical devices and unapproved new drugs.

The UNICO ST8 Acupuncture needles were cited as an adulterated device under section 501(f)(1)(B) of the Act because Kenshin Trading Corporation lacked an approved premarket approval (PMA) or investigational device exemption (IDE). The device was also misbranded under section 502(o) for failure to submit a 510(k) premarket notification.

Additionally, several products, including Katsu Natto-Kinase Tablets, Katsu Kelp Root Tablets, Shijimi Capsules, VitalFocus Sanza Capsules, Natural Tree Sap Pouch, and Shiunko Burn Cream, were deemed unapproved new drugs under section 201(g) and 201(p) of the Act due to therapeutic claims on the website. These claims, such as "fight osteoporosis" for Katsu Natto Kinase Tablets and "helpful in lowering blood pressure" for Katsu Kelp Root Tablets, establish the products as drugs intended for disease treatment or affecting body function. The Shiunko Burn Cream was specifically noted as not conforming to the OTC Skin Protect

Company
Kenshin Trading Corporation
Inspection date
November 30, 2009
Product type
Devices
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • William S. Vitale (Compliance Officer)
View Company Profile

ID · 9112e56f-c973-43d7-8dab-0fc14a01b648

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)21 CFR 807.81(b)21 U.S.C. 321(p)21.U.S.C. 355(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kenshin Trading Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.